Page last updated: 2024-10-24

chlorambucil and Polychondritis, Relapsing

chlorambucil has been researched along with Polychondritis, Relapsing in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Polychondritis, Relapsing: An acquired disease of unknown etiology, chronic course, and tendency to recur. It is characterized by inflammation and degeneration of cartilage and can result in deformities such as floppy ear and saddle nose. Loss of cartilage in the respiratory tract can lead to respiratory obstruction.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bochtler, T1
Hensel, M1
Lorenz, HM1
Ho, AD1
Mahlknecht, U1

Other Studies

1 other study available for chlorambucil and Polychondritis, Relapsing

ArticleYear
Chronic lymphocytic leukaemia and concomitant relapsing polychondritis: a report on one treatment for the combined manifestation of two diseases.
    Rheumatology (Oxford, England), 2005, Volume: 44, Issue:9

    Topics: Antineoplastic Agents, Alkylating; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Ear Ca

2005